long-acting interferon drug product company in Hepatitis and Cytokines
Home / Recombinant Protein Product[copy]202401

AMOYTOP Recombinant Protein

Amoytop Biotech is an innovative biopharmaceutical company in China, specializing in R&D, manufacturing and marketing of regular and long-acting recombinant protein drugs. It has grown into a leading enterprise in the field of pegylated protein drugs in China. Amoytop Biotech works on better solutions to major diseases including viral hepatitis and malignant tumor, and on immunotherapy as well. Possessing innovation ability from basic research, pilot-scale research, clinical study to industrialization, Amoytop Biotech has established a complete biopharmaceutical innovation system. Up till now, Amoytop has developed 5 therapeutic biotechnological products, Pegbing (Mipeginterferon alfa-2b), Pegneugen (Telpegfilgrastim), Topleucon (Molgramostim), Topneuter (Filgrastim) and Topmega (Oprelvekin).

Among them, as a first-line drug for antiviral treatment of CHB, Pegbing has been further recognized by experts and patients for improving the clinical cure rate of CHB patients and reducing the risk of liver cancer. The other four products are mainly indicated for the treatment of neutropenia, leucopenia and thrombocytopenia resulting from cancer radiotherapy or chemotherapy.

Clinical Applications - Recombinant Protein Products

Pegbing (Mipeginterferon Alfa-2b)

First-Line Drug for CHB Patients to Achieve Clinical Cure
 1st 40kD Y-shape branched PEG modified interferon alfa-2b injection in the world
 Exclusive international patent Y-shape PEG structure improves drug stability
 Selective pegylation at high activity site results in higher antiviral activity
 Lower incidence of neutralizing antibody brings higher possibility to achieve SVR

Pegneugen (Telpegfilgrastim Injection)

New Generation of Long-Acting Filgrastim Drug Product
 Longer half-life, reaching 56.9-90 hours (traditional PEG-huG-CSF only 40-56.8 hours)
 Equivalent efficacy, lower dosage (only 1/3 of other launched PEG-Filgrastim)
 Lower risk, higher cost-effectiveness

Biological Reagents: Recombinant Proteins (Research Use Only)

Amoytop Biotech is devoted to constant innovation in blopharmaceutical field and strive to expand product variety. Now Amoytop Biotech has independently developed and produced a series of lyophilized powder reagents for laboratory use as well as liquid reagent products (such as hirudin, Protein A, Protein G, etc.).
 Independent research         High purity, high activity
 FDA DMF filing                       CNAS
 Customization services

Innovating Protein Production

Why Choose AMOYTOP Biotech

ECONOMY IS MORE AFFORABLE
SPECIALIZED IN PRODUCT
Great value enjoyment
This area can be fully edited and gives you the opportunity to introduce yourself, your website, your products or your services.
First-rate service
This area can be fully edited and gives you the opportunity to introduce yourself, your website, your products or your services.
First-class quality
This area can be fully edited and gives you the opportunity to introduce yourself, your website, your products or your services.
Economy is more affordable
This area can be fully edited and gives you the opportunity to introduce yourself, your website, your products or your services.
OUR MISSION
CLASSES
EDUCATION
LEADERSHIP
Strength & character are only the beginning
Military School provides young boys with an exemplary, academic platform that acknowledges the differences regarding how each individual learns while also eliminating distractions. Under the military model, cadets at Military School develop a sense of self-confidence.
Read more
Strength & character are only the beginning
Military School provides young boys with an exemplary, academic platform that acknowledges the differences regarding how each individual learns while also eliminating distractions. Under the military model, cadets at Military School develop a sense of self-confidence.
Read more
Strength & character are only the beginning
Military School provides young boys with an exemplary, academic platform that acknowledges the differences regarding how each individual learns while also eliminating distractions. Under the military model, cadets at Military School develop a sense of self-confidence.
Read more
Strength & character are only the beginning
Military School provides young boys with an exemplary, academic platform that acknowledges the differences regarding how each individual learns while also eliminating distractions. Under the military model, cadets at Military School develop a sense of self-confidence.
Read more
Global customers
The quality is very good, completely consistent with the seller's description, very satisfied, really like it, completely beyond expectations. The quality is very good, completely consistent with the seller's description, very satisfied, really like it, completely beyond expectations, the delivery speed is very fast, the packaging is very careful and strict, the service attitude of the logistics company is very good…
REASONABLE PRICE
1 -
  • Popular trust
      This area
    This area can be fully edited and gives you the opportunity to introduce 
  • Professional spirit
      This area
    This area can be fully edited and gives you the opportunity to introduce 
  • Professional quality
      This area
    This area can be fully edited and gives you the opportunity to introduce 
  • Popular trust
      This area
    This area can be fully edited and gives you the opportunity to introduce 
Related Product News​​​​​​​

New LOGO Comes on Stage: Amoytop Biotech Improves Its Brand Image.

On January 17, Tebao Biotech held a brand image upgrade launch ceremony in Xiamen. The company's brand visual image was fully refreshed and upgraded, and a new brand LOGO and brand upgrade promotional video were released, marking the official launch of Tebao Biotech's new brand development strategy.

2023-06-12
20240327-165119_889_667_877_493.jpg
2023-06-12
New LOGO Comes on Stage: Amoytop Biotech Improves Its Brand Image.

On January 17, Tebao Biotech held a brand image upgrade launch ceremony in Xiamen. The company's brand visual image was fully refreshed and upgraded, and a new brand LOGO and brand upgrade promotional video were released, marking the official launch of Tebao Biotech's new brand development strategy.

READ MORE

Launch of New Product-Pegneugen (Telpegfilgrastim Injection)

Xiamen, China, July 1, 2023/--Xiamen Amoytop Biotech Co., Ltd. (referred to as Amoytop Biotech hereinafter) today announced that Pegneugen® (Telpegfilgrastim Injection) has been approved by National Medical Products Administration (NMPA) and is available for marketing.

2023-07-01
20240327-165323.jpg
2023-07-01
Launch of New Product-Pegneugen (Telpegfilgrastim Injection)

Xiamen, China, July 1, 2023/--Xiamen Amoytop Biotech Co., Ltd. (referred to as Amoytop Biotech hereinafter) today announced that Pegneugen® (Telpegfilgrastim Injection) has been approved by National Medical Products Administration (NMPA) and is available for marketing.

READ MORE

Counselor of the State Council and former deputy director of NDRC Hu Zucai and his delegation visit Amoytop.

On October 19, Hu Zucai, counselor of the State Council and former deputy director of the National Development and Reform Commission, accompanied by leaders of the governments of Fujian Province, Xiamen City and Haicang District, visited Tebao Biotech for investigation. Sun Li, chairman and general manager of Tebao Biotech, received the visiting leaders and gave a detailed report on the company's production, operation and development plans, and focused on the role of Pegbin (long-acting interferon) in improving the clinical cure rate of hepatitis B and reducing the risk of liver cancer. research progress in this regard.

2023-10-19
1710298979484 - 副本 (3).jpg
2023-10-19
Counselor of the State Council and former deputy director of NDRC Hu Zucai and his delegation visit Amoytop.

On October 19, Hu Zucai, counselor of the State Council and former deputy director of the National Development and Reform Commission, accompanied by leaders of the governments of Fujian Province, Xiamen City and Haicang District, visited Tebao Biotech for investigation. Sun Li, chairman and general manager of Tebao Biotech, received the visiting leaders and gave a detailed report on the company's production, operation and development plans, and focused on the role of Pegbin (long-acting interferon) in improving the clinical cure rate of hepatitis B and reducing the risk of liver cancer. research progress in this regard.

READ MORE

Amoytop's Quality Center awarded CNAS certificate

Recently, Amoytop's Quality Center was awarded the certificate issued by China National Accreditation Service for Conformity Assessment (CNAS) (Certificate number: CNAS L4479).

2023-09-15
1710298979484 - 副本 (3).jpg
2023-09-15
Amoytop's Quality Center awarded CNAS certificate

Recently, Amoytop's Quality Center was awarded the certificate issued by China National Accreditation Service for Conformity Assessment (CNAS) (Certificate number: CNAS L4479).

READ MORE

Looking For Professional Recombinant Protein Product Manufacturer?

You May Like

Drug Products
API
Reagents

Connect With Recombinant Protein Experts

 +86-592-6889106 / +86-18060918257
 No. 330 Wengjiao Road, Haicang, Xiamen Fujian, P.R.China
Get In Touch With Amoytop Biotech
0+
National innovation team in priority area
0+
Core technology platforms
0+
Launched drug products
0+
National Major Scientific and Technological Special Projects for Significant New Drug Development

Company Culture

Vision

To be a Leading International Biopharmaceutical Company in China

Mission

Devoted to Constant Innovation in Biopharmaceutical Field for a Better and Healthier Life for Human

Core Value

Responsibility丨Fairness丨Performance丨Win-Win
  • Social Responsibility
  • Social Responsibility

    ​​​​​​​Great ships require deep waters; swift horses cover great distances. “Realizing the value of technology and knowledge by transforming them into products and services to benefit patients” is the initial mission and intention insisted on by Amoytop Biotech. As a pharmaceutical enterprise, promoting the development of the biomedical industry and providing a healthier life for more patients are the main social responsibility of Amoytop Biotech.
Facebook
Twitter
LinkedIn
Instagram

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Leave a Message
Get In Touch